Jan Barthelmes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jan Barthelmes has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Sarah Dünnhaupt
ThioMatrix GmbH, Research Center Innsbruck, Trientlgasse 65, Innsbruck, Austria
10 shared publicationsAndreas Bernkop-Schnürch
9 shared publications- Andreas Bernkop-Schnürch
Department of Pharmaceutical Technology Institute of Pharmacy University of Innsbruck Innsbruck Austria
9 shared publications Glen Perera
7 shared publicationsDeni Rahmat
Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzens-University of Innsbruck, Innsbruck, Austria
4 shared publicationsClemens C. Thurner
ThioMatrix GmbH, Research Center Innsbruck, Trientlgasse 65, 6020 Innsbruck, Austria
3 shared publications
Latest Publications
- 1 March 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 250, 1-8
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model
- 1 March 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 250, 1-8
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model
- Open Access
- 1 December 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 172 (3) , 872-878
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats
- 1 December 2013
- Published by Elsevier in Journal of Controlled Release
- Vol. 172 (3) , 872-878
Open AccessLiposomes coated with thiolated chitosan enhance oral peptide delivery to rats
- 1 November 2013
- Published by Elsevier in Phytomedicine
- Vol. 20 (14) , 1306-1314
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055
- 1 November 2013
- Published by Elsevier in Phytomedicine
- Vol. 20 (14) , 1306-1314
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055
- 1 February 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 83 (2) , 149-155
Thiolated hydroxyethyl cellulose: Design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles
- 1 February 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 83 (2) , 149-155
Thiolated hydroxyethyl cellulose: Design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles
- Open Access
- 21 January 2013
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 4 (7) , 2342-2352
Thinking continuously: a microreactor for the production and scale-up of biodegradable, self-assembled nanoparticles
Scale-up of nanoparticle batch productions continues to be a major challenge in the pharmaceutical nanotechnology. Continuously operating microreactors have great potential to circumvent the scale-up difficulties. In this work a passive microreactor was used for the first time for the electrostatic self-assembly of biodegradable, mucoadhesive thiomer–protamine nanoparticles for drug delivery. The influence of three different parameters (the overall flow rate, the educt mass ratio and the molecular weight of the thiomer) on the particle characteristics was tested for the microreactor production and compared to the results of a successful 1 ml-batch reaction. As the flow rate increased (2, 5, 9, 16 ml min−1), the particle sizes and the polydispersity indexes decreased. In addition, the protamine : 5 kDa thiomer binding ratio and hence the zeta potential, as a measure of the suspension's stability, increased to >+40 mV due to better mixing during the microreactor production at a flow rate of 16 ml min−1. Producing nanoparticles from different mass ratios of 5 kDa thiomer : protamine (1 : 1, 1 : 3, 1 : 5) in the microreactor at this flow rate resulted in smaller particles with more distinct zeta potentials than those prepared by the 1 ml-batch reaction. Using a higher molecular weight thiomer (30 kDa) for the microreactor production at a flow rate of 16 ml min−1 led to slightly increased mean particle sizes (125.0 nm) compared to those produced by the 1 ml-batch reaction (102.9 nm). However, there was still a decrease in the width of the particle size distributions. In addition to the experimental work, a numerical model based on the population balance equation was developed. The results presented in this paper are in agreement with the experimental findings, especially with regard to the trends of decreased particle size and polydispersity with the increasing flow rate. The model results confirm that mixing effects to a great extent determine the particle size distribution of the resulting nanoparticles and show that spatial inhomogeneity of the mixing process must be taken into account. The unprecedented use of a passive microreactor for the production of biodegradable thiomer–protamine nanoparticles by electrostatic self-assembly was a success. Due to the reactor's continuous way of operation, not only were the scale-up problems of batch reactions overcome, but particle characteristics were also improved because of a better mixing effect.
- 21 January 2013
- Published by Royal Society of Chemistry (RSC) in Polymer Chemistry
- Vol. 4 (7) , 2342-2352
Open AccessThinking continuously: a microreactor for the production and scale-up of biodegradable, self-assembled nanoparticles
Scale-up of nanoparticle batch productions continues to be a major challenge in the pharmaceutical nanotechnology. Continuously operating microreactors have great potential to circumvent the scale-up difficulties. In this work a passive microreactor was used for the first time for the electrostatic self-assembly of biodegradable, mucoadhesive thiomer–protamine nanoparticles for drug delivery. The influence of three different parameters (the overall flow rate, the educt mass ratio and the molecular weight of the thiomer) on the particle characteristics was tested for the microreactor production and compared to the results of a successful 1 ml-batch reaction. As the flow rate increased (2, 5, 9, 16 ml min−1), the particle sizes and the polydispersity indexes decreased. In addition, the protamine : 5 kDa thiomer binding ratio and hence the zeta potential, as a measure of the suspension's stability, increased to >+40 mV due to better mixing during the microreactor production at a flow rate of 16 ml min−1. Producing nanoparticles from different mass ratios of 5 kDa thiomer : protamine (1 : 1, 1 : 3, 1 : 5) in the microreactor at this flow rate resulted in smaller particles with more distinct zeta potentials than those prepared by the 1 ml-batch reaction. Using a higher molecular weight thiomer (30 kDa) for the microreactor production at a flow rate of 16 ml min−1 led to slightly increased mean particle sizes (125.0 nm) compared to those produced by the 1 ml-batch reaction (102.9 nm). However, there was still a decrease in the width of the particle size distributions. In addition to the experimental work, a numerical model based on the population balance equation was developed. The results presented in this paper are in agreement with the experimental findings, especially with regard to the trends of decreased particle size and polydispersity with the increasing flow rate. The model results confirm that mixing effects to a great extent determine the particle size distribution of the resulting nanoparticles and show that spatial inhomogeneity of the mixing process must be taken into account. The unprecedented use of a passive microreactor for the production of biodegradable thiomer–protamine nanoparticles by electrostatic self-assembly was a success. Due to the reactor's continuous way of operation, not only were the scale-up problems of batch reactions overcome, but particle characteristics were also improved because of a better mixing effect.
- 20 December 2012
- Published by Taylor & Francis in Nanomedicine
- Vol. 8 (1) , 65-75
Thiolated Particles as Effective Intravesical Drug Delivery Systems for Treatment of Bladder-Related Diseases
Aim: To prove in vivo mucoadhesiveness of thiolated and well-established polymeric microparticles and nanoparticles (NPs) as a promising nanomedical tool for the treatment of bladder-related diseases. Materials & methods: Spray drying and ionic gelation were used in order to generate microparticles and NPs. For particle detection, the fluorescent marker, fluorescein diacetate, was incorporated in microparticles and NPs, respectively. Mucoadhesive properties of the particles were pre-evaluated via rheological measurements and ex vivo in the porcine urinary bladder model to identify the most appropriate particles for in vivo application in female Sprague Dawley rats. Results: Pretrials indicated that particles based on chitosan were most suitable as an intravesical drug delivery system for in vivo application. The retention time of thiolated chitosan NPs on the rat urinary bladder mucosa was approximately 170-fold higher in comparison with the pure fluorescent marker, fluorescein diacetate, having being app...
- 20 December 2012
- Published by Taylor & Francis in Nanomedicine
- Vol. 8 (1) , 65-75
Thiolated Particles as Effective Intravesical Drug Delivery Systems for Treatment of Bladder-Related Diseases
Aim: To prove in vivo mucoadhesiveness of thiolated and well-established polymeric microparticles and nanoparticles (NPs) as a promising nanomedical tool for the treatment of bladder-related diseases. Materials & methods: Spray drying and ionic gelation were used in order to generate microparticles and NPs. For particle detection, the fluorescent marker, fluorescein diacetate, was incorporated in microparticles and NPs, respectively. Mucoadhesive properties of the particles were pre-evaluated via rheological measurements and ex vivo in the porcine urinary bladder model to identify the most appropriate particles for in vivo application in female Sprague Dawley rats. Results: Pretrials indicated that particles based on chitosan were most suitable as an intravesical drug delivery system for in vivo application. The retention time of thiolated chitosan NPs on the rat urinary bladder mucosa was approximately 170-fold higher in comparison with the pure fluorescent marker, fluorescein diacetate, having being app...
- Open Access
- 1 October 2012
- Published by Elsevier in Carbohydrate Polymers
- Vol. 90 (2) , 765-772
S-protected thiolated chitosan: Synthesis and in vitro characterization
- 1 October 2012
- Published by Elsevier in Carbohydrate Polymers
- Vol. 90 (2) , 765-772
Open AccessS-protected thiolated chitosan: Synthesis and in vitro characterization
- 7 September 2012
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 13 (10) , 3054-3063
Synthesis and In Vitro Characterization of a Preactivated Thiomer via Polymerization Reaction
The objective of this study was to synthesize 6-(2-acryloylamino-ethyldisulfanyl)-nicotinic acid (ACENA) for subsequent copolymerization with acrylic acid (AA) as a new method for synthesis of preactivated thiomers. Copolymerization reactions of ACENA and AA with different molar ratios were performed and the molecular weight (Mw) values of the resulting copolymers were calculated and reported from 3046 to 3271 Da. The disulfide bond content values in the polymer chain were determined from 400 to 544 μmol disulfide bond per gram polymer. The transport enhancement ratio for 0.5% (m/v) solution of poly(acrylic acid) (PAA) was 1.1 using sodium fluorescein (Na-Flu) as model drug, in Ussing-type chambers, whereas it was over 1.9 for 0.5% (m/v) solution of ACENA and AA copolymers. Resazurin cell-viability test showed no significant toxicity for the polymers. Copolymerization of AA and disulfide-bond-containing monomers can open new horizons for the preparation of preactivated thiomers taking the better controllability and the huge variety of available monomers and combinations thereof into account.
- 7 September 2012
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 13 (10) , 3054-3063
Synthesis and In Vitro Characterization of a Preactivated Thiomer via Polymerization Reaction
The objective of this study was to synthesize 6-(2-acryloylamino-ethyldisulfanyl)-nicotinic acid (ACENA) for subsequent copolymerization with acrylic acid (AA) as a new method for synthesis of preactivated thiomers. Copolymerization reactions of ACENA and AA with different molar ratios were performed and the molecular weight (Mw) values of the resulting copolymers were calculated and reported from 3046 to 3271 Da. The disulfide bond content values in the polymer chain were determined from 400 to 544 μmol disulfide bond per gram polymer. The transport enhancement ratio for 0.5% (m/v) solution of poly(acrylic acid) (PAA) was 1.1 using sodium fluorescein (Na-Flu) as model drug, in Ussing-type chambers, whereas it was over 1.9 for 0.5% (m/v) solution of ACENA and AA copolymers. Resazurin cell-viability test showed no significant toxicity for the polymers. Copolymerization of AA and disulfide-bond-containing monomers can open new horizons for the preparation of preactivated thiomers taking the better controllability and the huge variety of available monomers and combinations thereof into account.
- 1 June 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 160 (3) , 477-485
In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan
- 1 June 2012
- Published by Elsevier in Journal of Controlled Release
- Vol. 160 (3) , 477-485
In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan